LAS VEGAS, Dec. 5, 2016 /PRNewswire/ -- BD (Becton,
Dickinson and Company) (NYSE: BDX), a leading global medical
technology company, will demonstrate an enhanced technology
platform designed with the ability to synchronize BD medication
management technologies, including the company's leading Pyxis™ and
Alaris™ systems, at this year's American Society of Health-System
Pharmacists (ASHP) 2016 Midyear Meeting being held in Las Vegas from Dec.
4-8.
While national data show that approximately 68 percent of
medication errors occur during the administration phase, errors can
happen during any step of the medication management
processi. During last year's ASHP Midyear Meeting, BD
revealed how its strong portfolio of solutions can help improve the
safety and cost of healthcare during each step of the process.
Since then, BD is continuing its focus on creating a new enterprise
medication management platform that will harmonize its advanced
technologies to close the communication gaps between devices and
help optimize the entire medication management process. This unique
approach is coupled with new services, backed by clinical experts
that will support a hospital or health system to define, execute
and measure its medication management processes and continuously
improve workflows and optimize processes.
"BD is a leader in medication management technologies because of
our continued commitment to innovation and deep understanding of
the customer challenges with medications," said Ranjeet Banerjee, worldwide president of
Medication Management Solutions for BD. "We know it's not enough to
simply have the right technologies in place if they aren't
connected to other parts of the process. BD's innovation roadmap
includes device hardware, interoperability software, data analytics
applications and services creating an interconnected system that is
designed to help improve outcomes across the continuum of
care."
During ASHP, BD will showcase the medication management
processes and illustrate how medication safety and efficiency can
be enhanced across the care continuum by combining three key
elements to improve customer outcomes:
- Medication Management Platform Innovation: From
medication reconciliation upon admission, dispensing in the
pharmacy and administration at the bedside, BD will showcase
leading technologies to help hospitals and health systems manage
inventory, prepare IV medications and safely dispense and
administer medications along with tracking technologies to know
where medications are from the pharmacy to the bedside.
- Advanced Data and Analytics: New BD analytics
applications can provide recommendations on ways to optimize the
medication management system for peak safety and efficiency, which
complements EHR data and helps improve workflow and patient
safety.
- Customer-centric Support and Services: BD is
implementing new services that will help hospitals and health
systems review and understand its own medication management data
and determine opportunities to improve outcomes.
For more information, or to register for any of the BD-sponsored
activities at ASHP, please visit us at Booth #821.
About BD
BD is a global medical technology company
that is advancing the world of health by improving medical
discovery, diagnostics and the delivery of care. BD leads in
patient and health care worker safety and the technologies that
enable medical research and clinical laboratories. The company
provides innovative solutions that help advance medical research
and genomics, enhance the diagnosis of infectious disease and
cancer, improve medication management, promote infection
prevention, equip surgical and interventional procedures, and
support the management of diabetes. The company partners with
organizations around the world to address some of the most
challenging global health issues. BD has more than 40,000
associates across 50 countries who work in close collaboration with
customers and partners to help enhance outcomes, lower health care
delivery costs, increase efficiencies, improve health care safety
and expand access to health. For more information on BD, please
visit bd.com.
This press release contains certain estimates and other
forward-looking statements (as defined under Federal securities
laws) regarding potential future sales and product development.
Forward looking statements may be identified by use of words such
as "will", "plan", "believe", "expect" or other words of similar
meaning. All such statements are based upon the current
expectations of BD and involve a number of business risks and
uncertainties. Actual results could vary materially from
anticipated results described, implied or projected in any
forward-looking statement. A number of factors could cause actual
results to vary materially, including, without limitation,
difficulties inherent in product development, delays in product
introductions and uncertainty of market acceptance of new products;
competitive factors including technological advances and new
products introduced by competitors; pricing and market pressures;
potential cuts in governmental healthcare spending and measures to
contain healthcare costs; adverse changes in regional, national or
foreign economic conditions; product efficacy or safety concerns;
fluctuations in costs and availability of materials and in BD's
ability to maintain favorable supplier arrangements and
relationships; new or changing laws and regulations impacting our
business or changes in enforcement practices with respect to such
laws; future healthcare reform; as well as other factors discussed
in BD's filings with the Securities and Exchange Commission. We do
not intend to update any forward-looking statements to reflect
events or circumstances after the date hereof except as required by
applicable laws or regulations.
i California Hospital Patient Safety Organization
(2012, October). Patient Safety News. 4(9).
|
|
Contacts:
|
|
|
|
Matt
Coppola
|
Monique N.
Dolecki
|
BD Public
Relations
|
BD Investor
Relations
|
201.847.7370
|
201.847.5378
|
matthew_r_coppola@bd.com
|
monique_dolecki@bd.com
|
|
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/bd-integrating-technology-expertise-and-services-to-provide-comprehensive-medication-management-300372889.html
SOURCE BD (Becton, Dickinson and Company)